New patent for Glaxosmithkline drug OJJAARABy DrugPatentWatch – Make Better Decisions / May 23, 2024 Annual Drug Patent Expirations for OJJAARA Ojjaara is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are three patents protecting…Source